Joseph Anderson, Ph.D., M.A.S.
Associate Professor
Locations and Contact
Research/Academic Interests
Dr. Anderson’s research interests includes developing stem cell gene therapies for HIV and multiple rare diseases. He designs and evaluates the therapies in disease-specific models to determine their efficacy toward clinical phenotypes. If successful, he is able to move these forward into clinical trials.
Division
Infectious Diseases
Center/Program Affiliation
Northern California Center for AIDS Research
Institute for Regenerative Cures
Stem Cell Research Program
Undergraduate School
B.S., University of Wisconsin, La Crosse WI 2000
Other School
Ph.D., Microbiology, Colorado State University, Fort Collins CO 2005
Other School
M.A.S., Clinical Research, UC Davis, Sacramento CA 2012
Acceptance into the UC Davis Mentored Clinical Research Training Program., 2013
UC Davis Academic Federation Travel Award 2011, 2012, 2013
UC Davis Academic Federation Innovative Development Award, 2012
First place award for poster at "Medical Student Research and Poster Forum" at UC-Davis Medical Center, Symposium, 2009
American Society of Hematology Travel Award for abstract poster presentation at ASH conference, 2008
Adhikari A, Copping NA, Beegle J, Cameron DL, Deng P, O'Geen H, Segal DJ, Fink KD, Silverman JL, Anderson JS. Functional rescue in an Angelman syndrome model following treatment with lentivector transduced hematopoietic stem cells. Hum Mol Genet. 2021 Jun 9;30(12):1067-1083. doi:10.1093/hmg/ddab104. PMID:33856035.
Beegle J, Hendrix K, Maciel H, Nolta JA, Anderson JS. Improvement of motor and behavioral activity in Sandhoff mice transplanted with human CD34+ cells transduced with a HexA/HexB expressing lentiviral vector. J Gene Med. 2020 Sep;22(9):e3205. doi:10.1002/jgm.3205. Epub 2020 May 7. PMID:32335981.
Barclay SL, Yang Y, Zhang S, Fong R, Barraza A, Nolta JA, Torbett BE, Abedi M, Bauer G, Anderson JS. Safety and efficacy of a tCD25 preselective combination anti-HIV lentiviral vector in human hematopoietic stem and progenitor cells. Stem Cells. 2015 Mar;33(3):870-9. doi:10.1002/stem.1919. PMID:25524029.
Kalomoiris S, Lawson J, Chen RX, Bauer G, Nolta JA, Anderson JS. CD25 preselective anti-HIV vectors for improved HIV gene therapy. Hum Gene Ther Methods. 2012 Dec;23(6):366-75. doi:10.1089/hgtb.2012.142. Epub 2013 Jan 11. PMID:23216020.